Power your medicine
NBTX-IV is an aqueous suspension containing crystalline hafnium oxide nanoparticles, with a specific coating designed to optimize bioavailability when injected into the bloodstream.
NBTX-IV nanoparticles are designed for intravenous injection so that the product can reach the tumor and surrounding lymph nodes, which may already be invaded locally by cancer cells.
Increased tumor destruction and potentially reduce the subsequent escape of malignant cells localized in neighboring lymph nodes.
This product from Nanobiotix’s proprietary NanoXray platform is in preclinical development. The product has been selected by the National Cancer Institute’s (NCI) Nanotechnology Characterization Laboratory (NCL) for characterization on the basis of its potential to impact cancer treatment.
Potential indications for this product
Targeted indications are brain metastasis and advanced stage tumors that have invaded surrounding lymph nodes, such as rectal cancer or lung carcinoma…